Trials / Terminated
TerminatedNCT00486798
FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the efficacy of quetiapine IR, following rapid titration versus conventional titration in patients with acute psychosis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Quetiapine | |
| PROCEDURE | Rating Scales | |
| PROCEDURE | Self Assessment Form | |
| PROCEDURE | Blood and urine samples | |
| PROCEDURE | Sleeping pattern |
Timeline
- Start date
- 2007-05-01
- Primary completion
- 2007-08-01
- Completion
- 2007-08-01
- First posted
- 2007-06-15
- Last updated
- 2010-12-10
Locations
13 sites across 1 country: Sweden
Source: ClinicalTrials.gov record NCT00486798. Inclusion in this directory is not an endorsement.